Karo Pharma AB buy Morgan Stanley
Start price
26.06.25
/
50%
€5.44
Target price
26.06.26
€45.35
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 26.06.26. The prediction end date can be changed by Morgan_Stanley at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karo Pharma AB | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat